Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_assertion description "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_provenance.
• NP222935.RAgKmXoe4PKGSfkp2S7YilGwgbWgMndMdsFpww9mXvnCE130_assertion description "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222935.RAgKmXoe4PKGSfkp2S7YilGwgbWgMndMdsFpww9mXvnCE130_provenance.
• NP317022.RAMqeLRjgfSyE1NEbWsNpfUE6pduOx4EnWR4aoO-hp3Kw130_assertion description "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317022.RAMqeLRjgfSyE1NEbWsNpfUE6pduOx4EnWR4aoO-hp3Kw130_provenance.
• assertion description "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP651598.RA6-kPX44Z0tG3sRrqaKGsCY8I627KIZPtB2Bky8O8Wxk130_assertion description "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651598.RA6-kPX44Z0tG3sRrqaKGsCY8I627KIZPtB2Bky8O8Wxk130_provenance.
• assertion description "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP660496.RAVaMCy8uUEYe0txZvyAYrlGpxcmXiQ8nBiBurVU0FCtg130_assertion description "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660496.RAVaMCy8uUEYe0txZvyAYrlGpxcmXiQ8nBiBurVU0FCtg130_provenance.
• NP375051.RArpIO5e5jjAgzgcuIAi9XBE2Sojj_c-2pCcQEuYac4kg130_assertion description "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375051.RArpIO5e5jjAgzgcuIAi9XBE2Sojj_c-2pCcQEuYac4kg130_provenance.
• NP647316.RAiQauFwdjHxqlPZU9GqAFOW0QdTCYSAvoaYa0F8ya9cg130_assertion description "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP647316.RAiQauFwdjHxqlPZU9GqAFOW0QdTCYSAvoaYa0F8ya9cg130_provenance.
• NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_assertion description "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_provenance.
• NP660498.RAlP_xxIOWa7elue_8LJq1eAyNU6sdqpI_G35bgjUeDts130_assertion description "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660498.RAlP_xxIOWa7elue_8LJq1eAyNU6sdqpI_G35bgjUeDts130_provenance.